The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, published in Gastroenterology. This ...

AGA living guideline recommends patients start advanced therapies early in their disease course rather than gradual step-up treatment approach. “Since the first biologic treatment for ulcerative ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment with ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

It’s becoming more common to treat ulcerative colitis with two biologic medications, or a biologic and a small molecule drug.

A crucial part of caring for ulcerative colitis (UC) patients is implementing good health maintenance practices, including those aimed at preventing complications from the disease itself, as well as ...

Ulcerative colitis (UC) is a chronic immune-mediated idiopathic inflammatory disorder characterized by colonic inflammation which typically begins in the rectum and extends proximally. The disease ...

Nearly 70% of adolescents and young adults stop taking oral 5-aminosalicylic acid (5-ASA) maintenance therapy within 12 months of ulcerative colitis (UC) diagnosis, new research from the United ...